Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 March 2025
- Conf. stmt due
- 16 September 2027
- Last conf. stmt
- 2 September 2026
Epidarex Exeed Limited
- Incorporated
- 16 August 2019 (7 years)
- Previously known as
- Project Seedco Limited (until 11 October 2019)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- Accounts type
- Small
- Region
- Scotland
- Address
- 137A George StreetEdinburghEH2 4JY
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 26 September 2019
British
Born July 1967 (59)
Director · Appointed 16 August 2019
Irish
Born July 1974 (52)
Director · Appointed 16 August 2019
German
Born November 1969
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 16 August 2019
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporate
Reg. no. Sl033678
Group structure 26 shown
Ownership group derived from the Companies House PSC register
BBB Investment Holdings Limited Owns 75–100% of shares
BBB Investment Services Limited Owns 75–100% of shares
BBB Mandates Limited Owns 75–100% of shares
BGP General Partner I LLP Holds 75–100% of voting rights
British Business Access Lending Limited Owns 75–100% of shares
British Business Investments Ltd Owns 75–100% of shares
Federated Hermes Private Equity Innovation II LP Part right to 25–50% of surplus assets
Hermes Gpe Environmental Innovation Fund LP Part right to 25–50% of surplus assets
Hermes Gpe Innovation Fund LP Part right to 25–50% of surplus assets
UK FTF L.P. Holds 25–50% of voting rights
British Patient Capital Limited Owns 75–100% of shares
Epidarex Capital IV, LP Part right to 25–50% of surplus assets
Nations and Regions Investments Limited Owns 75–100% of shares
British Business Finance Ltd Owns 75–100% of shares
British Business Aspire Holdco Ltd Owns 75–100% of shares
Capital for Enterprise Fund L.P. Holds 50–75% of voting rights
Epidarex Capital Iii UK, LP Part right to 25–50% of surplus assets
Epidarex Exeed Limited This company Owns 75–100% of shares
Lario Therapeutics Limited Owns 50–75% of shares
Macomics Ltd Owns 25–50% of shares
Rinn Therapeutics Limited Owns 75–100% of shares
Passion Capital GC (FP) LLP Right to 50–75% of surplus assets
Pentech Fund Iii Limited Partnership Part right to 25–50% of surplus assets
The Start-Up Loans Company Right to appoint and remove directors
Financials
Figures from 2023 accounts. Newer accounts, made up to 31 March 2025, are filed but not read yet. See them on Companies House
- Cash
- £1,010,574
- Profit
- (£845,538)
- Employees
- 2
- Current Ratio
- 6.1x
- Return on Equity
- -77%
Balance sheet detail
| 2023 | |
|---|---|
| Fixed Assets | £4,108 |
| Current Assets | £1,301,673 |
| Debtors | £291,099 |
| Cash | £1,010,574 |
| Creditors (< 1 year) | £214,089 |
| Net Current Assets | £1,087,584 |
| Shareholder Funds | £1,091,692 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 8 September 2026 | Confirmation statement with no updates | 2 September 2026 |
Some other companies at this address
Other companies in this industry
Cambridge
Cambridge
Abingdon
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →